X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (22) 22
prinomastat (19) 19
animals (16) 16
humans (16) 16
matrix metalloproteinase inhibitors (15) 15
angiogenesis (11) 11
oncology (10) 10
cancer (9) 9
mice (9) 9
metastasis (8) 8
pharmacology & pharmacy (8) 8
antineoplastic agents - therapeutic use (7) 7
endothelial growth-factor (7) 7
female (7) 7
matrix metalloproteinases (7) 7
batimastat (6) 6
expression (6) 6
antineoplastic agents - pharmacology (5) 5
extracellular-matrix (5) 5
matrix metalloproteinase (5) 5
medicine & public health (5) 5
ophthalmology (5) 5
prinomastat ag3340 (5) 5
rats (5) 5
ag3340 (4) 4
biochemistry & molecular biology (4) 4
carcinoma (4) 4
endothelial-cells (4) 4
enzyme inhibitors - pharmacology (4) 4
invasion (4) 4
matrix metalloproteinases - metabolism (4) 4
mmp inhibitor (4) 4
neoplasm invasiveness (4) 4
neoplasm transplantation (4) 4
neoplasms - drug therapy (4) 4
organic chemicals (4) 4
organic chemicals - therapeutic use (4) 4
pharmacology/toxicology (4) 4
protease inhibitors - therapeutic use (4) 4
antitumor efficacy (3) 3
cell biology (3) 3
clinical trials as topic (3) 3
dosage and administration (3) 3
enzyme inhibitors - therapeutic use (3) 3
gelatinase (3) 3
immunohistochemistry (3) 3
inhibitor (3) 3
internal medicine (3) 3
male (3) 3
metalloproteinase (3) 3
neoplasm metastasis (3) 3
organic chemicals - administration & dosage (3) 3
pharmacotherapy (3) 3
research (3) 3
research and development (3) 3
tissue inhibitor (3) 3
toxicology (3) 3
tumor-growth (3) 3
a-deficient mice (2) 2
adenocarcinoma (2) 2
adenocarcinoma - drug therapy (2) 2
affinity (2) 2
angiogenesis inhibitors (2) 2
angiostatin (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - chemistry (2) 2
article (2) 2
care and treatment (2) 2
cell line, tumor (2) 2
chemistry, medicinal (2) 2
chemotherapy (2) 2
choroidal neovascularization - drug therapy (2) 2
collagenase (2) 2
cyclodextrin (2) 2
disease models, animal (2) 2
disease progression (2) 2
drug design (2) 2
enzyme inhibitors - pharmacokinetics (2) 2
fluorescein angiography (2) 2
gelatinase-b (2) 2
genetics & heredity (2) 2
glioblastoma (2) 2
injections (2) 2
integrin (2) 2
integrins (2) 2
iv collagenase (2) 2
macular degeneration (2) 2
marimastat (2) 2
matrix metalloproteinase 2 - metabolism (2) 2
matrix metalloproteinases - chemistry (2) 2
matrix metalloproteinases - genetics (2) 2
matrix metalloproteinases - physiology (2) 2
matrix-metalloproteinase inhibitor (2) 2
mice, inbred c57bl (2) 2
mice, nude (2) 2
mice, scid (2) 2
mmp inhibitors (2) 2
model (2) 2
murine model (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer Research, ISSN 0008-5472, 12/2001, Volume 61, Issue 23, pp. 8480 - 8485
Journal Article
ACS Biomaterials Science and Engineering, ISSN 2373-9878, 03/2017, Volume 3, Issue 3, pp. 238 - 242
Journal Article
Investigational New Drugs, ISSN 0167-6997, 3/2006, Volume 24, Issue 2, pp. 135 - 140
Journal Article
Journal Article
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, ISSN 0275-004X, 02/2006, Volume 26, Issue 2, pp. 202 - 209
Purpose: To evaluate the inhibitory effects of a urokinase-derived octapeptide, A degrees 6, on laser-induced choroidal neovascularization (CNV) in monkeys.... 
choroidal neovascularization | SUBRETINAL NEOVASCULARIZATION | angiogenesis | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | MACULAR DEGENERATION | RECEPTOR | PRINOMASTAT AG3340 | MATRIX METALLOPROTEINASES | ENDOTHELIAL-CELLS | OPHTHALMOLOGY | FIBROBLAST GROWTH-FACTOR | animal model | age-related macular degeneration | EXPRESSION | RETINAL-PIGMENT EPITHELIUM
Journal Article
Lung Cancer, ISSN 0169-5002, 2003, Volume 42, Issue 3, pp. 335 - 344
We studied the synthetic matrix metalloproteinase inhibitor (MMPI) prinomastat (AG3340) in a well-established NCI-H460 orthotopic lung cancer model that... 
Matrix metalloproteinase (MMP) | H460 orthotopic lung cancer model | AG3340 | Chemotherapy | MMP inhibitor (MMPI) | Prinomastat | ACTIVATION | BATIMASTAT | prinomastat | chemotherapy | THERAPY | ONCOLOGY | RESPIRATORY SYSTEM | MICE | MATRIX-METALLOPROTEINASE INHIBITOR | TUMOR-GROWTH | CARCINOMA | matrix metatioproteindse (MMP) | NUDE RAT | ANTITUMOR EFFICACY | Immunohistochemistry | Lung Neoplasms - drug therapy | Neoplasm Transplantation | Matrix Metalloproteinases - genetics | Lung Neoplasms - mortality | Humans | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | RNA, Messenger - metabolism | Rats, Nude | Tissue Inhibitor of Metalloproteinases - genetics | Carboplatin - therapeutic use | Neoplasm Metastasis - prevention & control | Neovascularization, Pathologic - prevention & control | Lung - metabolism | Organic Chemicals - administration & dosage | Tissue Inhibitor of Metalloproteinases - analysis | RNA, Messenger - genetics | Carboplatin - administration & dosage | Organic Chemicals - therapeutic use | Rats | Matrix Metalloproteinases - analysis | Survival Rate | Treatment Outcome | Random Allocation | Xenograft Model Antitumor Assays | Blotting, Northern | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lung - drug effects | Cell Line, Tumor | Matrix Metalloproteinase Inhibitors | Lung - blood supply | Index Medicus
Journal Article
ACS BIOMATERIALS SCIENCE & ENGINEERING, ISSN 2373-9878, 03/2017, Volume 3, Issue 3, pp. 238 - 242
Glioblastoma multiforme patients suffer a median survival of 14 months, facilitated by the highly invasive nature of this cancer that allows for it to evade... 
MATERIALS SCIENCE, BIOMATERIALS | prinomastat | NEWLY-DIAGNOSED GLIOBLASTOMA | cyclodextrin | AG3340 | matrix met alloproteinase | MODEL | glioblastoma | invasion | INHIBITOR | TUMOR-GROWTH | CARMUSTINE | BRAIN | affinity
Journal Article
Journal Article
Journal Article
Journal Article
Expert Opinion on Therapeutic Patents, ISSN 1354-3776, 01/2001, Volume 11, Issue 1, pp. 77 - 114
Angiogenesis refers to the formation of capillary blood vessels from existing blood vessels: a process that is believed to be critical for tumour growth and... 
7E3 | marimastat | fumagillin | vasostatin | endostatin | avβ3 | KDR | metallopharmaceuticals | hydroxamate | hypoxia | antibody | FGF | kininogen | angiogenesis | TKIs | uPA | vascular endothelial growth factor (VEGF) | angiopoietin | RGD | thrombospondin | collagenase | cilengitide | cytochalasin E | vitronectin | restin | Trk A | matrix metalloproteinases (MMPs) | angiostatin | Tie-2 | tumstatin | SU-6668 | SU-5416 | arrestin | canstatin | Flt | receptor tyrosine kinases inhibitors (TKIs) | metastasis | tumour | HUVEC | uPAR | integrin | stromelysin | PTK 787 | prinomastat | urokinase | platelet derived growth factor (PDGF) | kringle | MMP inhibitor (MMPI) | plasminogen | TNP-470 | Tek | TIMP | Vascular endothelial growth factor (VEGF) | UPA | Cytochalasin E | Vitronectin | Arrestin | Metastasis | Angiogenesis | Urokinase | Kininogen | Hydroxamate | Integrin | Platelet derived growth factor (PDGF) | Matrix metalloproteinases (MMPs) | Tumour | Antibody | Restin | UPAR | Prinomastat | Hypoxia | Plasminogen | Fumagillin | Metallopharmaceuticals | Stromelysin | Vasostatin | Kringle | Angiopoietin | Endostatin | MMp inhibitor (MMPI) | Marimastat | Tumstatin | Canstatin | Thrombospondin | Receptor tyrosine kinases inhibitors (TKIs) | Collagenase | Cilengitide | Angiostatin | vasular endothelial growth factor (VEGF) | PHARMACOLOGY & PHARMACY | ENDOTHELIAL GROWTH-FACTOR | MEDICINE, LEGAL | alpha(v)beta | BINDING | NEOVASCULARIZATION
Journal Article